1,469 results match your criteria: "Neurosarcoidosis"

Objective: To present a case series analysis of surgical treatment of patients with secondary trigeminal neuralgia.

Material And Methods: The treatment of 8 patients with secondary trigeminal neuralgia who underwent surgery since 2021 was analyzed. All records, neuroimaging archive, and follow-up observations were reviewed.

View Article and Find Full Text PDF

Purpose: Sarcoidosis, a multi-organ granulomatous disease, occasionally involves the nervous system, presenting as neurosarcoidosis. The following case demonstrates a potential association between COVID-19 and brain and spinal cord injury mimicking neurosarcoidosis.

Case Description: A 51-year-old woman presented with persistent holocranial headache, nausea, vertigo, and neurological deficits one month after a COVID-19 hospitalization.

View Article and Find Full Text PDF

Sarcoidosis is an immune-mediated multisystem condition of unknown etiology, characterized by non-caseating granulomatous inflammation. While it commonly affects the lungs and the reticuloendothelial system, it can affect any organ. Most of such cases involve the central nervous system, but the condition rarely presents with symptoms related to hypothalamic-pituitary dysfunction.

View Article and Find Full Text PDF

Neurosarcoidosis, particularly in the absence of extra-neurologic systemic manifestations of sarcoidosis, is a challenging diagnosis that has a wide array of presentations. Most often presenting with cranial neuropathies, basilar meningitis or pituitary/hypothalamic dysfunction, isolated involvement of the spinal cord without cranial manifestations is exceptionally rare, often involving intramedullary lesions. Here, we present the unique case of a 64-year-old female with atypical neurosarcoidosis presenting with myelopathy from extra-dural nodules without other neurologic or systemic symptoms.

View Article and Find Full Text PDF

Primary hemophagocytic lymphohistiocytosis (HLH) is a rare, often fatal immune disorder characterized by an overactivation of the immune system. This disease is more common in children but has been known to occur in the occasional adult. The criteria for diagnosis in children do not correlate well with diagnosis in adults, and the numerous variations of presentation in adults often lead to a delay in diagnosis and treatment initiation.

View Article and Find Full Text PDF
Article Synopsis
  • * Diagnosing sarcoidosis is challenging due to its diverse presentations and the absence of specific biomarkers, leading to complications in understanding its course and treatment.
  • * The review emphasizes the need for new diagnostic criteria and recommends developing a reliable immunological or imaging marker to improve diagnosis and prognosis for patients with chronic sarcoidosis.
View Article and Find Full Text PDF

Diagnostic and Therapeutic Insights Into Pediatric Neurosarcoidosis: Observations From French Pediatric Rheumatology Centers.

Pediatr Neurol

January 2025

Department of General Pediatrics, Pediatric Internal Medicine, Rheumatology and Infectious Diseases, National Reference Centre for Rare Pediatric Inflammatory Rheumatisms and Systemic Autoimmune Diseases (RAISE), Robert-Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Université Paris Cité, INSERM, Centre de Recherche sur l'inflammation UMR 1149, Paris, France. Electronic address:

Article Synopsis
  • - The study reviewed 11 pediatric patients diagnosed with neurosarcoidosis (NS), predominantly affecting girls, with an average diagnosis age of around 10 to 11.5 years, highlighting typical neurological symptoms such as headaches and eye involvement.
  • - Most patients experienced meningitis and were treated primarily with corticosteroids and TNF-alpha inhibitors, with eight out of 11 requiring biologic therapies to achieve remission.
  • - The findings emphasize the importance of recognizing the clinical features of pediatric NS and suggest that early intervention with TNF-alpha biologics can lead to better management outcomes for these children.
View Article and Find Full Text PDF

Case report: Rapid diagnosis followed by rapid remission of neurosarcoidosis.

Int J Rheum Dis

November 2024

Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan.

View Article and Find Full Text PDF

Progressive multifocal leukoencephalopathy (PML) is a rare central nervous system disease caused by JC virus (JCV) infection. Human immunodeficiency virus (HIV) infection is the greatest risk factor for PML. Other immunological diseases, including systemic sarcoidosis, have also been reported as risk factors for PML.

View Article and Find Full Text PDF

Neurosarcoidosis Masquerading as Spinal Stenosis.

Diagnostics (Basel)

October 2024

Rheumatology Unit, Carmel Medical Center, Haifa 3436212, Israel.

Article Synopsis
  • A 65-year-old woman experienced progressive pain, weakness in limbs, and urinary incontinence, leading to a hospitalization for evaluation of a suspected demyelinating disease.
  • MRI showed spinal cord compression due to complex disc issues and localized enhancement, prompting further tests to rule out infections and malignancies.
  • The patient was ultimately diagnosed with both neurosarcoidosis and spondylotic myelopathy, and after treatment, she showed significant clinical and radiographic improvement.
View Article and Find Full Text PDF
Article Synopsis
  • Neurosarcoidosis is a rare form of sarcoidosis that affects the nervous system, leading to symptoms like seizures, cognitive issues, and cranial nerve problems, which complicate diagnosis and management due to their variability.
  • Diagnosing the condition requires a mix of clinical assessments, advanced imaging (like high-resolution MRI and PET scans), and lab tests, but it can be mistaken for conditions like multiple sclerosis.
  • Treatment often starts with corticosteroids and may include immunosuppressants or biologic therapies for more severe cases, with ongoing research aimed at better understanding the disease and improving therapies through biomarkers and innovative technologies.
View Article and Find Full Text PDF
Article Synopsis
  • Neurosarcoidosis is a rare form of sarcoidosis that complicates the nervous system, making it challenging to diagnose and treat due to its diverse symptoms.
  • A case of a 67-year-old man showed signs like altered sensorium and weight loss, leading to tests that eventually diagnosed him with neurosarcoidosis based on imaging and biopsy results.
  • Treatment with prednisolone and methotrexate resulted in significant improvement, illustrating the need for a multidisciplinary approach in handling such complex cases.
View Article and Find Full Text PDF

Extrapulmonary sarcoidosis.

J Autoimmun

December 2024

Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.

Article Synopsis
  • - Sarcoidosis is a chronic inflammatory disease that arises in genetically susceptible individuals after exposure to certain antigens, primarily affecting the lungs but potentially impacting any organ, including the heart, nervous system, and eyes, which can lead to severe complications.
  • - Diagnosis is typically easier when typical symptoms and biopsy findings are present, but it becomes more complex when symptoms manifest in areas outside the lungs without accompanying lung issues.
  • - First-line treatment for sarcoidosis involves corticosteroids, while immunosuppressive or biologic medications are used for patients who do not respond to steroids or have refractory disease.
View Article and Find Full Text PDF
Article Synopsis
  • - Neurosarcoidosis is a condition where noncaseating granulomas, typical of sarcoidosis, are present in the nervous system, affecting areas like the brain and spinal cord.
  • - The case report discusses a 57-year-old man experiencing progressive weakness and numbness in his legs, as well as eye issues, which led to further testing.
  • - Imaging revealed lymph node enlargement, and biopsies confirmed the presence of granulomas, suggesting neurosarcoidosis; thus, doctors should consider this diagnosis when patients exhibit similar symptoms for timely treatment.
View Article and Find Full Text PDF
Article Synopsis
  • - The case discusses a 64-year-old woman with a complex set of symptoms including difficulty speaking and swallowing, which led to the consideration of various potential diagnoses, including neurosarcoidosis.
  • - Diagnostic procedures revealed cranial nerve palsies; while MRI was inconclusive, CT scans indicated vocal cord paralysis, and lab tests showed elevated CSF biomarker levels, supporting the diagnosis of neurosarcoidosis.
  • - Treatment with steroids and infliximab showed significant improvement in her symptoms and highlights the importance of CSF sIL-2R as a useful biomarker while also promoting the use of steroid-sparing therapies in managing the condition.
View Article and Find Full Text PDF
Article Synopsis
  • - A 62-year-old woman with multiple health issues, including neurologic problems from neurosarcoidosis, experienced worsening symptoms like headaches, weakness, and vomiting, alongside a problematic brain mass detected via MRI.
  • - During her hospital stay, she experienced a syncopal episode, EKG changes, and declining mental status, leading to imaging revealing acute ischemic changes in her brain and vascular stenosis.
  • - Despite not qualifying for certain treatments, the patient received a combination of medications, including aspirin and immunosuppressants (IV cyclophosphamide), which managed her condition related to systemic vasculitis associated with her neurosarcoidosis.
View Article and Find Full Text PDF

The differential diagnosis of suspected multiple sclerosis has been developed using data from North America, northern Europe, and Australasia, with a focus on White populations. People from minority ethnic and racial backgrounds in regions where prevalence of multiple sclerosis is high are more often negatively affected by social determinants of health, compared with White people in these regions. A better understanding of changing demographics, the clinical characteristics of people from minority ethnic or racial backgrounds, and the social challenges they face might facilitate equitable clinical approaches when considering a diagnosis of multiple sclerosis.

View Article and Find Full Text PDF

Neurosarcoidosis is a condition that is characterized by the occurrence of noncaseating epithelioid granulomas in various organs throughout the body, including the lungs, heart, and central nervous system. It is particularly prevalent in cases of noncommunicating hydrocephalus. While its clinical presentations may vary, neurological deficits such as hemiparesis are extremely uncommon.

View Article and Find Full Text PDF

Introduction: Neurosarcoidosis (NS) is a systemic inflammatory granulomatous disease affecting of patients with sarcoidosis. Its diagnosis is difficult as there is no specific test for it. Because of its rarity, the management of NS has so far only been described in case series and short retrospective cohorts.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze the clinical features, radiological outcomes, treatments, and long-term follow-up of patients diagnosed with spinal cord neurosarcoidosis over a 25-year period at a single medical center.
  • A total of 39 patients were reviewed, with most showing extensive intramedullary lesions and common symptoms like neuropathic pain and weakness, leading to a prevalent use of corticosteroids and methotrexate for treatment.
  • Follow-up MRI results indicated improvements over time, with a notable percentage of patients experiencing complete resolution of MRI enhancements, highlighting the need for better diagnostic clarity and treatment guidelines due to the complexity of the condition.
View Article and Find Full Text PDF

Sarcoidosis is a systemic inflammatory disease that affects diverse organs such as the lungs, skin, eyes, and brain. Osseous involvement in sarcoidosis usually affects bones of the appendages with direct infiltration of non-caseating granulomas without bony infarcts. Symptoms of sarcoid bone lesions respond well to corticosteroid therapy.

View Article and Find Full Text PDF

In neuroinflammatory diseases, systemic (blood-borne) leukocytes invade the central nervous system (CNS) and lead to tissue damage. A causal relationship between neuroinflammatory diseases and dysregulated cytokine networks is well established across several preclinical models. Cytokine dysregulation is also observed as an inadvertent effect of cancer immunotherapy, where it often leads to neuroinflammation.

View Article and Find Full Text PDF